Navigation Links
Emerson Resources Announces CEO Retirement and Appointment of Successor
Date:5/21/2013

Norristown, PA (PRWEB) May 21, 2013

Emerson Resources Inc., a premier pharmaceutical development company, today announced that Dr. Charles Signorino, the Company’s Chief Executive Officer and Chairman of the Board, retired on April 1, 2013 after 32 years of service. As part of Emerson Resources’ planned leadership succession process, Adolfo Gomez, Emerson’s current President, has been named as Dr. Signorino’s successor.

Dr. Signorino is a recognized luminary in the pharmaceutical industry, having made a significant contribution to the field during his extensive career. He is an established expert in many aspects of tablet coating and holds 17 U.S. patents related to the area. Additionally, he is named in Who’s Who of American Scientists, has been published in numerous technical journals over the past three decades, and is a member of key industry organizations.

He joined Emerson Resources in 1981 as President and Chairman of the Board, following 20 years of service at Colorcon Inc. as Vice President and member of the Board of Directors. Dr. Signorino was elected CEO of Emerson Resources in 2002, based on his visionary leadership and notable expertise in Emerson’s core areas of focus. During his tenure at Emerson Resources, Dr. Signorino also formed CS Associates, a contract lab for coating services, in 1987.

“The entire team at Emerson Resources would like to express our gratitude to Dr. Signorino for his lifelong dedication to the field, as well as his steadfast service to the Company,” said Adolfo Gomez, President. “Dr. Signorino has set the bar very high for me as his successor. He has not only established the Company as a global name in the pharmaceutical and nutritional supplement industries, he has also inspired the Company with his strategic vision, passion for lifelong learning and strong family values.

Adolfo Gomez, a Principal of the Company with more than 20 years of industry experience, joined Emerson Resources in 2001. In his role as President, he has been responsible for managing every aspect of the business, with a specific focus on Business Development and Strategy. Mr. Gomez is credited for his instrumental role in diversifying Emerson Resources’ business model to include partnerships with industry leading organizations, as well as working very closely with Emerson’s management team to ensure adherence to the company’s core values.

In his new role as CEO, Mr. Gomez will continue implement a strategic plan that centers on three key areas of focus for the Company. These areas include:

  •     Ensuring the Company remains focused on helping clients with their drug development strategies that will allow them to bring their molecules to market as quickly and efficiently as possible.
  •     Maintaining the dynamic culture of creativity and ownership that differentiates Emerson Resources from the competition.
  •     Staying on the forefront of cutting edge technologies that allow the Company to maintain its reputation as an excellent problem solver, with pragmatic yet creative solutions.

“I am delighted to pass the opportunity to build on Emerson Resources’ history of innovation, service and success to Mr. Gomez," said Dr. Signorino. "He is a talented leader and I look forward to supporting him as he moves the Company to its next level of growth.”

About Emerson Resources
Emerson Resources’ reputation as a dependable, dynamic, flexible, and pragmatic
organization has been built on the core concepts of excellent service, superb quality and
complete client satisfaction. The Emerson mission is to deliver value-added service,
ingredients and expertise to the pharmaceutical and biotech industries.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10746974.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Wiley Job Network Announces New Resources and Tools to Connect Job Seekers and Employers
2. Touch Medical Media Splits From Touch Briefings, Launches a Series of Cutting Edge, Free to Access, Educational Resources and Signs an Updated Media Partnership With ECCO, The European CanCer Organisation Representing 60,000 Oncology Professionals
3. New Informatics and Bioimaging Center combines resources, expertise from UMD, UMB
4. Walgreens Joins with Ferring Pharmaceuticals Inc. to Offer Products and Resources to Women Facing Fertility Complications from Cancer Treatment
5. Cepheid Welcomes Senior Vice President of Human Resources
6. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
7. Revolutionary Science Announces New Automatic and Manual Colony Counting Products
8. Nanonex Announces the Shipment and Installation of an Innovative Nanoimprint Lithography System for Fully Automated Manufacturing
9. SoundConnect Announces Microsoft Lync Release in Canada
10. GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit
11. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... of a United States multicenter, prospective clinical study that demonstrates the accuracy ... test capable of identifying clinically significant acute bacterial and viral respiratory tract ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research ... Inc. has been selected for membership in ARCS Alumni Hall of Fame ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... announced today it will be hosting a Webinar titled, “Pathology is going digital. ... Associates , on digital pathology adoption best practices and how Proscia improves lab ...
(Date:10/11/2017)... ... 2017 , ... A new study published in Fertility and ... in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort study ... comparing the results from the fresh and frozen transfer cohorts, the authors of ...
Breaking Biology Technology:
(Date:5/6/2017)... May 5, 2017 RAM Group ... a new breakthrough in biometric authentication based on ... mechanical properties to perform biometric authentication. These new sensors ... material created by Ram Group and its partners. This ... transportation, supply chains and security. Ram Group is ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
(Date:4/13/2017)... , April 13, 2017 According to a ... Identity Authentication, Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment ... the IAM Market is expected to grow from USD 14.30 Billion in ... Rate (CAGR) of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):